SMSMED — Scandinavian Medical Solutions A/S Income Statement
0.000.00%
Last trade - 00:00- DKK110.75m
- DKK159.33m
- DKK226.68m
- 62
- 49
- 17
- 34
Annual income statement for Scandinavian Medical Solutions A/S, fiscal year end - September 30th, DKK millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | DAS | DAS | DAS | DAS | DAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 41.9 | 71.6 | 111 | 191 | 227 |
| Cost of Revenue | |||||
| Gross Profit | 9.23 | 17.3 | 30.1 | 49.4 | 56.8 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 36 | 60.8 | 95.8 | 175 | 213 |
| Operating Profit | 5.96 | 10.9 | 14.7 | 16.6 | 13.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 5.82 | 10.5 | 14.7 | 15.8 | 10.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4.51 | 8.16 | 11.4 | 12.2 | 7.79 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 4.51 | 8.16 | 11.4 | 12.2 | 7.79 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4.51 | 8.16 | 11.4 | 12.2 | 7.79 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.166 | 0.299 | 0.426 | 0.448 | 0.284 |
| Dividends per Share |